Physician profile
Timothy Presnell
NPI 1013908466
$1,506.19
in general payments reported to CMS, 2019-2025
10 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $115 · 2021: $85.44 · 2022: $226 · 2023: $308 · 2024: $247 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $543.49 | 2022-2025 | Slynd |
| Amgen INC. | $236.99 | 2019-2021 | |
| Abbvie INC. | $203.94 | 2019-2022 | |
| Novo Nordisk INC | $168.65 | 2019-2023 | Wegovy |
| Exact Sciences Corporation | $144.42 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astellas Pharma US INC | $111.07 | 2023-2025 | Veozah |
| Boston Scientific Corporation | $47.65 | 2025 | General - Female Sui |
| Merck Sharp & Dohme LLC | $23.64 | 2019 | |
| Ascend Therapeutics US, LLC | $14.45 | 2022 | |
| Axonics, INC. | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Presnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.